Myelin gene expression in immortalized Schwann cells: relationship to cell density and proliferation.
Myelin gene expression was investigated in the immortalized S16 Schwann cell line grown in the presence and absence of serum and at different densities. Protein expression was monitored by western blotting, and message levels were determined by RNase protection assays. To study cell proliferation rates at different cell densities and serum conditions, [3H]thymidine uptake assays and cell counts were performed. Although serum deprivation decreased cell proliferation as expected, the proliferation of S16 cells was unchanged or slightly increased at high density under the conditions of our experiments in either serum-containing or serum-free medium. This increased cell division at high density appeared to be due to greater release of an autocrine growth factor to the medium by dense cell populations. For both sparse and dense cells, substantially more P0 glycoprotein (P0) and myelin-associated glycoprotein (MAG) per milligram of total cellular protein were expressed when the cells were proliferating slowly in defined medium in comparison with more rapidly proliferating cells in serum-containing medium. Furthermore, in both serum-containing and defined media, dense cell populations expressed more MAG and PO than sparse ones. PO mRNa and MAG mRNA levels generally paralleled protein levels. The level of mRNA for peripheral myelin protein-22 (PMP-22) was also increased at high cell density but did not change much when proliferation was decreased by serum deprivation. PMP-22 protein was not detected under any of the growth conditions. The changes in expression of these genes with growth conditions may be specific for myelin proteins, because the expression of a nonmyelin glycoprotein, L1, remained constant. The level of cyclic AMP in the cells did not change with the different growth conditions tested. The results indicate that the S16 Schwann cell line mimics primary or secondary Schwann cells by down-regulating myelin gene expression when it proliferates more rapidly in the presence of serum. Furthermore, in both the presence and absence of serum, there was greater expression of myelin genes at high cell density that was not associated with a decreased proliferative rate. Because evidence for a role of secretory factors in affecting myelin gene expression was not obtained by treating sparse S16 cells with medium conditioned by dense S16 cells, the results suggest that the higher expression of myelin genes at high density may be mediated by cell-to-cell contact.
Sasagasako
N
N
Myelin and Brain Development Section, Laboratory of Molecular and Cellular Neurobiology, NINDS, NIH, Bethesda, Maryland, USA.
Toda
K
K
Hollis
M
M
Quarles
R H
RH
D000818:Animals; D001483:Base Sequence; D001798:Blood Proteins / Q000494:pharmacology; D002452:Cell Count; D002455:Cell Division / Q000502:physiology; D002461:Cell Line, Transformed / Q000166:cytology / Q000502:physiology; D017077:Culture Media, Conditioned; D000242:Cyclic AMP / Q000378:metabolism; D005699:Galactosylceramides / Q000235:genetics; D015870:Gene Expression / Q000502:physiology; D008969:Molecular Sequence Data; D018993:Myelin P0 Protein / Q000235:genetics; D009185:Myelin Proteins / Q000235:genetics*; D018992:Myelin-Associated Glycoprotein / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D012583:Schwann Cells / Q000166:cytology / Q000502:physiology*; D013433:Sulfoglycosphingolipids / Q000378:metabolism
D001798:Blood Proteins; D017077:Culture Media, Conditioned; D005699:Galactosylceramides; D018993:Myelin P0 Protein; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein; D012333:RNA, Messenger; D013433:Sulfoglycosphingolipids; C002454:galactocerebroside; D000242:Cyclic AMP